Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

CellPro: Q2 1997 highlights

Nov. 6, 1997

Karo Bio/Merck & Co. form strategic alliance related to ER receptors

Nov. 5, 1997

FibroGen granted license to Zeneca antifibrotic compounds

Nov. 3, 1997

Genzyme General and Acadia enter drug discovery collaboration

Nov. 3, 1997

Laminin-like peptides available for licensing from NIH

Nov. 3, 1997

Genetic animal model of psychiatric disorders available for licensing

Oct. 30, 1997

Lilly and Chugai enter into combinatorial chemistry collaboration

Oct. 29, 1997

Dyax and Tularik establish drug discovery collaboration

Oct. 28, 1997

Structure of NO-producing enzyme solved

Oct. 28, 1997

Sibia's TBA technology licensed to Neurocrine Biosciences

Oct. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...